API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
Ferrous Sulphate SR (Sustained Release) Pellets are an oral iron supplement designed to replenish iron stores and treat or prevent iron deficiency anemia. The sustained-release formulation allows gradual release of iron, enhancing absorption, minimizing gastric irritation, and improving patient compliance compared to conventional iron salts.
| Component | Function |
|---|---|
| Ferrous Sulphate (FeSO₄) | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Spheres | Inert core or starter pellets |
| Hydroxypropyl Methylcellulose (HPMC) | Binder / Film former during layering |
| Talc / Colloidal Silicon Dioxide | Anti-adherent / Glidant |
| Ethyl Cellulose / HPMC / PVP | Sustained release polymer – controls iron release rate |
| Triethyl Citrate / PEG 6000 | Plasticizer (for sustained release coating) |
| Purified Water | Solvent (removed after processing) |
Outsourcing pellets through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance. Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Ferrous Sulphate SR Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
They are used in the treatment and prevention of iron deficiency anemia, particularly when a sustained and controlled release of iron is desired for better absorption and reduced gastrointestinal irritation.
Yes, they can be manufactured in compliance with USP, BP, or EP standards depending on market and regulatory requirements.
Typically supplied in bulk HDPE drums or aluminum foil bags, with customized packaging available for export.
Yes. Sustained release reduces peak concentrations of iron in the stomach, lowering the risk of gastric irritation and constipation.